However, cancer development is rarely associated with p73 mutations, with possible exceptions being loss in a subset of T-cell lymphomas and neuroblastoma [4,5], and no genetic disorder has been linked to p73, in direct contrast to p53 [6]. This evidence concerns the gene TP53 and cancer.